戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ythroid progenitors and eventually promoting erythroleukemia.
2 t to the development of Friend virus-induced erythroleukemia.
3 e for the resistance to Friend virus-induced erythroleukemia.
4 r the constitutively activated mutant caused erythroleukemia.
5 with GATA1 function, thereby contributing to erythroleukemia.
6 irus in check and developed fatal FV-induced erythroleukemia.
7 dysregulation of PU.1 expression can lead to erythroleukemia.
8 o directly address the role of p53 in Friend erythroleukemia.
9 y also have possible therapeutic utility for erythroleukemia.
10 ration of erythroid progenitors and inducing erythroleukemia.
11 also be a useful marker for the diagnosis of erythroleukemia.
12  ensued, most commonly lymphoid leukemia and erythroleukemia.
13 of the Moloney virus from T-cell leukemia to erythroleukemia.
14 d to the erythroid lineage, and induction of erythroleukemia.
15 xplanation of v-ErbA activity in AEV-induced erythroleukemia.
16 trongly associated with Friend virus-induced erythroleukemia.
17 ring the progression of Friend-virus-induced erythroleukemia.
18 forming virus (SFFV) results in a multistage erythroleukemia.
19 F1IP and MLF1 deregulation in the genesis of erythroleukemias.
20 globin but not beta-globin; transgenic mouse erythroleukemia 585 cells express predominantly human be
21      Fv-2 resistance to Friend virus-induced erythroleukemia acts through nonimmunological mechanisms
22 actor PU.1, an oncogene implicated in murine erythroleukemia, acts to functionally cross-antagonize o
23  those from mice susceptible to SFFV-induced erythroleukemia also express a short form of the recepto
24 ll mice exhibited accelerated progression to erythroleukemia and accelerated death following diagnosi
25 elated factor 2 (Nrf2) pathway in K562 human erythroleukemia and other cell types after treatment wit
26 ith AGI-6780 induced differentiation of TF-1 erythroleukemia and primary human acute myelogenous leuk
27 t in a broad range of malignancies including erythroleukemia and solid tumors.
28 lase 1 (HDAC1), and histone deacetylase 2 in erythroleukemia and T cell leukemia cells.
29 e exhibit decreased susceptibility to Friend erythroleukemia and that expansion of erythroid progenit
30 utes to both early and late stages of Friend erythroleukemia and that persistence of F-gp55 expressio
31 etion in Gab2 are less susceptible to Friend erythroleukemia and the expansion of erythroid progenito
32 s are >/= 20%, the disorder is classified as erythroleukemia, and when BM blasts are < 20%, as myelod
33           Further, the data demonstrate that erythroleukemias arising in Friend virus-infected p53 nu
34 ne leukemia virus (F-MuLV) in F-MuLV induced erythroleukemia, as well as that of the 10A1 and Graffi
35 ression may be required not only to initiate erythroleukemia but to also maintain erythroleukemia fol
36 ce does not independently prevent FV-induced erythroleukemia but works in concert with the immune sys
37 severe Friend virus-induced splenomegaly and erythroleukemia by 6 to 8 weeks postinfection.
38                         Here, we use a mouse erythroleukemia cell (MEL) system for studying how repet
39 ressed differentially before and after mouse erythroleukemia cell (MELC) induction.
40 oter during dimethyl sulfoxide-induced mouse erythroleukemia cell differentiation.
41 ty (3.1 nM) and specificity similar to mouse erythroleukemia cell HS2NF5.
42 ctivation function, we cotransfected a human erythroleukemia cell line (K562) with a locus control re
43         In non-B cell lines, like the murine erythroleukemia cell line (MEL), the most distal IgH con
44 amma-globin promoter complexes in K562 human erythroleukemia cell line and primary human fetal and ad
45                                Using a human erythroleukemia cell line and primary murine BM cells, w
46    This segment can be excised from an avian erythroleukemia cell line by restriction enzyme digestio
47    These segments were excised from an avian erythroleukemia cell line by restriction enzyme digestio
48                    When transfected into the erythroleukemia cell line Dami, promoter-luciferase cons
49                                       In the erythroleukemia cell line Dami, transfected promoter-luc
50 ylation of sf-Stk can also be detected in an erythroleukemia cell line derived from an SFFV-infected
51 e factors in the proliferation of the murine erythroleukemia cell line HCD57.
52 f JunB in the erythropoietin (EPO)-dependent erythroleukemia cell line HCD57.
53 livery of this transcription factor into the erythroleukemia cell line K562 resulted in an increase o
54 ated proapoptotic activity against the human erythroleukemia cell line K562.
55 romatin interactions for TFII-I in the human erythroleukemia cell line K562.
56 on to a 2-D gel separation of the same human erythroleukemia cell line lysate, the IEF-NP RP HPLC pro
57 inal erythroid differentiation of the murine erythroleukemia cell line MEL, whereas its overexpressio
58 screening, and lack of functional effects in erythroleukemia cell line TF-1 and CD34(+) progenitor ce
59 ony-stimulating factor (GM-CSF) in the human erythroleukemia cell line TF-1.
60 btraction cDNA library approach from a mouse erythroleukemia cell line that had been induced to polyp
61  detected in cells of the K562 line, a human erythroleukemia cell line, and in CD34+ primary human he
62                             However, a mouse erythroleukemia cell line, CB3, does not express hnRNP A
63                            In TF-1 cells, an erythroleukemia cell line, granulocyte-macrophage colony
64 er stable plasmid transfection of the murine erythroleukemia cell line, MEL585.
65                                        In an erythroleukemia cell line, TF-1, high levels of p105/p50
66 vely expressed in the factor-dependent human erythroleukemia cell line, TF1.
67     In contrast, studies with the K562 human erythroleukemia cell line, which is often used for compa
68 s well as EPO protein in K562 cells, a human erythroleukemia cell line.
69                   In contrast, the growth of erythroleukemia cell lines derived from Friend murine le
70 e JNK inhibitor blocked the proliferation of erythroleukemia cell lines derived from these mice.
71 ulation of PU.1 transcription in established erythroleukemia cell lines differed depending upon the l
72 ocytes from Friend SFFV-infected mice and in erythroleukemia cell lines from Friend MuLV-infected mic
73 ed mice but did not alter AP1 DNA binding in erythroleukemia cell lines from Friend SFFV-infected mic
74                    Studies of cultured mouse erythroleukemia cell lines indicate that one aspect of P
75                                    Two human erythroleukemia cell lines, HEL and K562, and a human pr
76                       We have established an erythroleukemia cell model to study how Notch regulates
77 n erythrocyte membranes and from K562 (human erythroleukemia) cell membranes, has robust peptidylprol
78 fR IgG3-Av) inhibits the proliferation of an erythroleukemia-cell line.
79 in undifferentiated and differentiated human erythroleukemia cells (HEL) using SEEL using the sialylt
80                We have previously shown that erythroleukemia cells (K562) transfected with vascular a
81  surface coreceptor for entry, we used human erythroleukemia cells (K562), which allow parvovirus B19
82 cell-mediated chromosome transfer into human erythroleukemia cells (K562).
83 lyzed the responses of HeLa cells and murine erythroleukemia cells (MELC) to hexamethylene bisacetami
84 tation assays and minigene-transfected mouse erythroleukemia cells (MELCs).
85 We have purified an mSin3A complex from K562 erythroleukemia cells and identified three new mSin3A-as
86 g directly and specifically to HS2 in living erythroleukemia cells and in mouse fetal liver.
87 s, into a defined chromosomal site in murine erythroleukemia cells and monitored the stability of the
88  using DNA-protein binding studies and human erythroleukemia cells and promoter activity using lucife
89  close to 100 % of negatively selected mouse erythroleukemia cells and ranges from 10 to 50 % in embr
90 of CR2 were expressed on the surface of K562 erythroleukemia cells and their binding ability assessed
91   CReP was also required for exocytosis from erythroleukemia cells and thus appears to play a broader
92    Attachment of B. burgdorferi N40 to human erythroleukemia cells and to human saphenous vein endoth
93 ogenous enzyme or cocultured with human K562 erythroleukemia cells as an exogenous source of TPI.
94                         With the use of DS19 erythroleukemia cells as model particles with frequency-
95       Induced overexpression of PU.1 in K562 erythroleukemia cells blocks hemin-induced erythroid dif
96 n of megakaryocytic differentiation of human erythroleukemia cells by 12-O-tetradecanoylphorbol-13-ac
97 er transfer of gamma globin genes into mouse erythroleukemia cells can be used for the analysis of re
98 To address this issue, we used hybrid murine erythroleukemia cells containing a single copy of human
99               In differentiated ES cells and erythroleukemia cells containing the LCR-deleted chromos
100 d (65)Zn uptake activity in transfected K562 erythroleukemia cells expressing hZip2 from the CMV prom
101 ude that two independent pathways operate in erythroleukemia cells for nitric oxide-mediated protecti
102   Recombinant OPN and BSP can protect murine erythroleukemia cells from attack by human complement as
103 In our preliminary study, we found that K562 erythroleukemia cells have an extremely low level of end
104 astoma cell line was cultured with the human erythroleukemia cells IA lacking PrP(C).
105  hSK1(-)(9b) is especially abundant in human erythroleukemia cells in culture.
106 onstructs transfected into NIH 3T3 and mouse erythroleukemia cells indicated that the housekeeping pr
107 cetylation increased significantly in murine erythroleukemia cells induced to differentiate in cultur
108  ADNP or ADNP2 in zebrafish embryos or mouse erythroleukemia cells inhibited erythroid maturation, wi
109 -globin gene expression is evident in murine erythroleukemia cells lacking the p45 subunit of NF-E2.
110  and FTE/S3a from lysates of Rauscher murine erythroleukemia cells overexpressing both proteins.
111 , we examined (65)Zn uptake activity in K562 erythroleukemia cells overexpressing hZIP1.
112 e expression of the -90 beta-ZF-DBD in mouse erythroleukemia cells reduced the binding of KLF1 with t
113 d chemosensitization was observed on K562/R7 erythroleukemia cells resistant to doxorubicin, especial
114 rgeted introduction of this allele into K562 erythroleukemia cells results in a proliferation defect
115                                         K562 erythroleukemia cells stably transfected with constructs
116 x transcript is expressed at lower levels in erythroleukemia cells than reticulocytes.
117                       A large panel of mouse erythroleukemia cells that bear a single copy of integra
118 TNF-alpha expression in the proliferation of erythroleukemia cells that is distinct from the effect o
119 nous Sias on transfected cells, and by using erythroleukemia cells to allow experimental manipulation
120 talin synthesis enhances sensitivity of K562 erythroleukemia cells to CDC, whereas overexpression of
121  study, we used nuclear extracts from murine erythroleukemia cells to purify a protein complex that b
122 hese compounds also induced HL-60 and murine erythroleukemia cells to undergo partial differentiation
123  have now analyzed laminin binding to murine erythroleukemia cells transfected with various human B-C
124                                         K562 erythroleukemia cells treated with the HbF inducers hemi
125                                        Mouse erythroleukemia cells treated with the phosphorothioate
126 ntegration into three defined loci in murine erythroleukemia cells using recombinase-mediated cassett
127 st extracellular loop of the P2Y(2)R to K562 erythroleukemia cells was inhibited by antibodies agains
128            We also show that AEV-transformed erythroleukemia cells were resistant to TGF-beta-induced
129              Finally, transfection of murine erythroleukemia cells with human B-CAM cDNA induces bind
130 megakaryocytes (and megakaryocyte-like human erythroleukemia cells), a regulatory role in cellular de
131 w levels of p53 (HeLa cells) or no p53 (K562 erythroleukemia cells).
132                         The adhesion of K562 erythroleukemia cells, a cell line expressing a single f
133 activated K+ channels of human erythrocytes, erythroleukemia cells, and ferret vascular smooth muscle
134 gulatory protein 2, in iron-deficient murine erythroleukemia cells, and in human patients with ISCU m
135 tial for erythroid differentiation of murine erythroleukemia cells, and serine/threonine phosphorylat
136 e mRNA was unchanged in iron-depleted murine erythroleukemia cells, and the stability of mature ferro
137 3 accelerates differentiation of both murine erythroleukemia cells, as well as fetal liver cells, whe
138 ene in both normal erythroid progenitors and erythroleukemia cells, as well as in macrophages.
139 thyl sulfoxide treatment of wild-type murine erythroleukemia cells, but not a mutant clone of dimethy
140 to the LCR occurs in undifferentiated murine erythroleukemia cells, but phosphorylation of LCR-associ
141  syngeneic fully autochthonous system (FBL-3 erythroleukemia cells, C57BL/6 mice, and highly purified
142  cytosine methyltransferase isoform in mouse erythroleukemia cells, Dnmt1, exhibits potent dead-end i
143 e assessed in stable transfectants of murine erythroleukemia cells, in which the activities of cyclin
144 on and reduced with RUNX1 knockdown in human erythroleukemia cells, indicating that PCTP is regulated
145 is required for beta-globin transcription in erythroleukemia cells, induces histone H3 hyperacetylati
146                                In K562 human erythroleukemia cells, knockdown of LPA2 enhanced erythr
147 also p53 mutants, such as p53 M133K in human erythroleukemia cells, leading to pathologic gene expres
148      In luciferase reporter studies in human erythroleukemia cells, mutation of each site decreased a
149              During differentiation of mouse erythroleukemia cells, protein levels of KCCs paralleled
150 3-integrin gene transcription in human K-562 erythroleukemia cells, Raf activation in NIH 3T3 cells l
151 in vitro erythroid differentiation in murine erythroleukemia cells, resulting in phenotypical cross-c
152                                    In murine erythroleukemia cells, the endogenous Lbd1 and LMO2 prot
153                                    In murine erythroleukemia cells, UNC0638 and Ehmt2 CRISPR/Cas9-med
154                                      In K562 erythroleukemia cells, we have identified four alternati
155 ) cDNA transfected into HeLa cells and mouse erythroleukemia cells, where it was expressed in the con
156                          Unlike SFFV-derived erythroleukemia cells, which depend on PU.1 expression f
157 formulate a metabolic model relevant to K562 erythroleukemia cells.
158 nit-erythroid-derived erythroblasts and TF-1 erythroleukemia cells.
159 of occupancy during differentiation of mouse erythroleukemia cells.
160 y complementation analysis in NF-E2-null CB3 erythroleukemia cells.
161 lacking hnRNP A1 was purified from CB3 mouse erythroleukemia cells.
162 to induce differentiation of cultured murine erythroleukemia cells.
163 a-globin promoter in undifferentiated murine erythroleukemia cells.
164 ared acetylation of the locus in MEL and CB3 erythroleukemia cells.
165 NA) is up-regulated after induction of mouse erythroleukemia cells.
166 th p50(cdc37) were detected in cultured K562 erythroleukemia cells.
167  inducing differentiation of cultured murine erythroleukemia cells.
168 rexpression enhances hemoglobin synthesis in erythroleukemia cells.
169 ) targeting this site (+60 ZF-DBD) in murine erythroleukemia cells.
170  substantial effect on toxicity toward human erythroleukemia cells.
171 ar extracts derived from hematopoietic human erythroleukemia cells.
172 ubregions of the LCR in human K562 and mouse erythroleukemia cells.
173 -geo reporter at three genomic sites in K562 erythroleukemia cells.
174 randomly chosen locus in the genome of mouse erythroleukemia cells.
175 uitment to the beta-globin promoter in mouse erythroleukemia cells.
176 pression was also demonstrated in K562 human erythroleukemia cells.
177 s an Epo upregulated gene in Rauscher murine erythroleukemia cells.
178 nce involved in inducible AQP1 regulation in erythroleukemia cells.
179 en characterized in hemin-treated human K562 erythroleukemia cells.
180 ted for the native MTase derived from murine erythroleukemia cells.
181  NK cell-susceptible targets, including K562 erythroleukemia cells.
182  and exon 1B to the proximal 3' ss in murine erythroleukemia cells.
183 hibitor JQ1 induced differentiation of mouse erythroleukemia cells.
184 etic cell lines, including 32DWT18 and human erythroleukemia cells.
185 ation of the virus-transformed cells, murine erythroleukemia cells.
186 ineered ribonuclease, is also toxic to human erythroleukemia cells.
187  after site-directed integration into murine erythroleukemia cells.
188 Runx1-regulated repression element in murine erythroleukemia cells.
189 in cell proliferation and/or the survival of erythroleukemia cells.
190 o search for Tal1/SCL target regions in K562 erythroleukemia cells.
191 ospho-STAT5; (iii) induce apoptosis in human erythroleukemia cells; and (iv) suppress pathologic cell
192 ith 10% to < 20% BM blasts from TNCs fulfill erythroleukemia criteria; however, by considering blasts
193 single-cell clones derived from HFV-infected erythroleukemia-derived cells (H92), there were up to 20
194 s a Stat3 target gene in the early stages of erythroleukemia development.
195 nitiate erythroleukemia but to also maintain erythroleukemia following Friend virus infection.
196 ally significant differences between NBM and erythroleukemia gene expression.
197  in vivo progression of Friend virus-induced erythroleukemia has been suggested but not clearly defin
198 nes, the mechanism by which gp55-A initiates erythroleukemia has remained a mystery.
199 re found with the JAK2(V617F)-positive human erythroleukemia HEL cell line.
200                                        Human erythroleukemia HEL cells showed AQP1 transcript express
201 -myristate 13-acetate (PMA)-stimulated human erythroleukemia (HEL) and CHRF 288-11 cells, which have
202 ed regulation of the serglycin gene in human erythroleukemia (HEL) and CHRF 288-11 cells, which have
203 iferation of the Jak2-V617F expressing human erythroleukemia (HEL) cell line by promoting marked cell
204                               When the human erythroleukemia (HEL) cell line is induced to differenti
205 he cellular action of NO, we inhibited human erythroleukemia (HEL) cell-surface PDI expression using
206                          Platelets and human erythroleukemia (HEL) cells also contained ER beta and A
207 ivation of endogenous alphaIIbbeta3 in human erythroleukemia (HEL) cells and beta1 integrin activatio
208                 We demonstrate in both human erythroleukemia (HEL) cells and primary human CD34(+) he
209 d in bipotential human cells (K562 and human erythroleukemia (HEL) cells), proerythroblastic mouse (M
210      Here, we used human platelets and human erythroleukemia (HEL) cells, which express integrin alph
211 rinostat-treated, JAK2V617F-expressing human erythroleukemia (HEL) cells.
212 f two independent cell lines, K562 and human erythroleukemia (HEL).
213 s of the cultured JAK2V617F-expressing human erythroleukemia HEL92.1.7 and Ba/F3-JAK2V617F cells.
214 lobin locus in a human fetal liver and mouse erythroleukemia hybrid cell (A181gamma cell) that contai
215 s of the spleen focus-forming virus initiate erythroleukemia in adult mice.
216 e and -resistant mice but is unable to cause erythroleukemia in Fv-2-resistant mice.
217 leen focus-forming virus (SFFV) causes rapid erythroleukemia in mice due to expression of its unique
218      Friend virus induces the development of erythroleukemia in mice through the interaction of a vir
219 ng the initial stage of Friend virus-induced erythroleukemia in mice, interaction of the viral protei
220                      Friend virus induces an erythroleukemia in susceptible mice that is initiated by
221 cute erythroid hyperplasia and eventually to erythroleukemia in susceptible strains of mice.
222  disease is essential for the progression of erythroleukemia in the presence of differentiation signa
223 n is a requirement for progression of Friend erythroleukemia in vivo.
224 ssion of PU.1 in erythroid precursors causes erythroleukemias in mice.
225 by proviral insertion or transgenesis causes erythroleukemias in mice.
226                                          The erythroleukemia induced by Friend virus is a multistage
227                                              Erythroleukemia induced by the anemia strain of Friend v
228  we replaced the U3 region of the LTR of the erythroleukemia-inducing Friend murine leukemia virus (F
229                                          The erythroleukemia-inducing Friend spleen focus-forming vir
230                                          The erythroleukemia-inducing Friend spleen focus-forming vir
231                                          The erythroleukemia-inducing Friend spleen focus-forming vir
232 rget cells, in vivo, cooperate to accelerate erythroleukemia induction.
233 ted mice, but caused a fatal, transplantable erythroleukemia instead.
234               Susceptibility to SFFV-induced erythroleukemia is conferred by the Fv-2 gene, which enc
235 positive) from shotgun analyses of the human erythroleukemia K562 cell line.
236 )-induced cytotoxicity in a subline of human erythroleukemia K562 cells (K/VP.5) and in K/VP.5 cells
237              We showed previously that human erythroleukemia K562 cells are resistant to antineoplast
238           Erythroid differentiation of human erythroleukemia K562 cells by hemin simultaneously incre
239 oduction was induced by glutamate, and human erythroleukemia K562 cells in which H(2)O(2) production
240 rmore, we detected the 2.8-kb PDGF-B mRNA in erythroleukemia K562 cells upon 12-O-tetradecanoylphorbo
241 arabine (Ara C)-dependent differentiation of erythroleukemia K562 cells, we observed effects that ind
242                   Incubation of the RNA with erythroleukemia K562 cytosolic extract results in deaden
243 , ZFP161) and measure reporter expression in erythroleukemia (K562) and liver carcinoma (HepG2) cell
244  of LEF to induce differentiation of a human erythroleukemia (K562) cell line and show that LEF induc
245                                     In human erythroleukemia (K562) cells, the highly related protein
246 n in both the DHL-4 B cell line and the K562 erythroleukemia line.
247 outs via CRISPR/Cas9 using the immortal JK-1 erythroleukemia line.
248 TfR2-alpha mRNA were significantly higher in erythroleukemia (M6) marrow samples than in nonmalignant
249 leukemia, suggesting that a key mechanism in erythroleukemia may be the collaboration of lesions dist
250 (SF2/ASF) expression in differentiated mouse erythroleukemia mediates a differentiation stage-specifi
251 sor mSin3A is associated with TAL1 in murine erythroleukemia (MEL) and human T-ALL cells.
252 d for production of stably transfected mouse erythroleukemia (MEL) cell clones and pools.
253   Herein we have derived stable Friend mouse erythroleukemia (MEL) cell clones expressing either Mfrn
254 cus before and after the induction of murine erythroleukemia (MEL) cell differentiation.
255 physically interacts with Mfrn1 during mouse erythroleukemia (MEL) cell differentiation.
256 erentiation block and can be grown as murine erythroleukemia (MEL) cell lines.
257 NF-related complex (PYR complex) from murine erythroleukemia (MEL) cell nuclear extract that binds py
258 ide (HMBA)-induced differentiation of murine erythroleukemia (MEL) cells and blocked differentiation;
259 y pathway is recapitulated in cultured mouse erythroleukemia (MEL) cells and targets nonsense-free mR
260                                       Murine erythroleukemia (MEL) cells are a model system to study
261                                Friend murine erythroleukemia (MEL) cells are transformed erythroid pr
262 ide (DMSO)-induced differentiation of murine erythroleukemia (MEL) cells as a model, transcription of
263 uring erythrocytic differentiation of murine erythroleukemia (MEL) cells induced by dimethylsulfoxide
264 nditional expression of C/EBPalpha in murine erythroleukemia (MEL) cells induced myeloid-specific gen
265 recipitate with Tal1 in extracts from murine erythroleukemia (MEL) cells induced to differentiate wit
266       The in vitro differentiation of murine erythroleukemia (MEL) cells is a dramatic example of tum
267                                        Mouse erythroleukemia (MEL) cells represent an important cell
268 ion of terminal differentiation in the mouse erythroleukemia (MEL) cells requires a decline in the le
269 ell lines, whereas A-kinase-deficient murine erythroleukemia (MEL) cells show impaired hemoglobin pro
270 in dynamics to the differentiation of murine erythroleukemia (MEL) cells, a model system for erythroi
271 ary conservation was established using mouse erythroleukemia (MEL) cells, a well studied erythropoies
272 ce adult erythroid differentiation in murine erythroleukemia (MEL) cells, but only SCFAs concurrently
273 er enhancement than the intact core in mouse erythroleukemia (MEL) cells, indicating the presence of
274                   We have cloned from murine erythroleukemia (MEL) cells, thymus, and stomach the cDN
275 tions from untreated and DMSO-treated Murine ErythroLeukemia (MEL) cells.
276 riptional unit in plasmid-transfected murine erythroleukemia (MEL) cells.
277  sulfoxide-induced differentiation of murine erythroleukemia (MEL) cells.
278 n normal and alpha-spectrin-deficient murine erythroleukemia (MEL) cells.
279 t (DeltaLCR) heterozygous mice and in murine erythroleukemia (MEL) cells.
280 s and the block to differentiation in murine erythroleukemia (MEL) cells.
281 ene expression from these mutations in mouse erythroleukemia (MEL) cells.
282 uring SAHA-induced differentiation of murine erythroleukemia (MEL) cells.
283 d probed for SAHA-binding proteins in murine erythroleukemia (MEL) cells.
284 rentiated, but not in differentiated, murine erythroleukemia (MEL) cells.
285 F) increase during differentiation of murine erythroleukemia (MEL) cells.
286  phosphorylation is not detectable in murine erythroleukemia (MEL) or other hematopoietic cells.
287 n and contributes to the formation of murine erythroleukemias (MEL).
288                 The Friend murine retroviral erythroleukemia model involves mitogenic activation of t
289 d mechanistic studies in the TF-1 IDH2 R140Q erythroleukemia model system and found that IDH2 mutant
290  which spontaneously recover from FV-induced erythroleukemia, neutralization of gamma interferon (IFN
291 n insertion in SB-induced JAK2V617F-positive erythroleukemias, present in 87.5% and 65%, respectively
292 r miR-92a, results in B-cell hyperplasia and erythroleukemia, respectively.
293 ious data demonstrating a role for MLF1IP in erythroleukemias, suggest a possible function for this p
294                      In Friend virus-induced erythroleukemia, the spleen focus-forming virus integrat
295                                       Friend erythroleukemia virus has long served as a paradigm for
296 fected cells that occurs early during Friend erythroleukemia virus infection.
297 elta(12)-PGJ(3) to mice infected with Friend erythroleukemia virus or those expressing the chronic my
298 ivation in another cell line-Rauscher murine erythroleukemia- which expresses the EPO receptor endoge
299 his disease had the overall appearance of an erythroleukemia, with an accumulation of immature erythr
300 jected into adult mice, SFFV induces a rapid erythroleukemia, with susceptibility being determined by

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top